Cambridge Major Laboratories, Inc.
Cambridge Major Laboratories, Inc. (www.c-mlabs.com) is a leading, global chemistry-based contract research organization (“CRO”) providing comprehensive chemistry outsourcing solutions to a diverse customer base, including some of the world’s largest pharmaceutical, small/mid-sized biotechnology, and generic drug companies. CML offers customers a broad array of chemistry services, delivering a complete life cycle of capabilities including process chemistry, solid state chemistry, analytical services, active pharmaceutical ingredients ("API") production services and regulatory services.
Arlington made an initial investment in CML in February 2007 and subsequently supported CML’s acquisition of ChemShop B.V. in November 2007.
In 2012, Cambridge Major Laboratories, Inc. was sold to publicly traded American Capital, Limited.
(Press Release for Acquisition of ChemShop B.V.)
(Press Release for Investment in CML, Inc.)
(Press Release for sale of Cambridge Major Laboratories, Inc. to American Capital Limited)